Pfizer adds second Phase 3 berobenatide knee osteoarthritis trial, completes Phase 2b VESPER-3Nov 6Weekly roundup, 13 itemsberobenatidemarstacimab-hncqUpdated
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Hepion Pharmaceuticals acquires Gravitas Life Sciences, installs new CEOOct 9M&AHepion Pharmaceuticals, Inc
Lyell completes LYL273 manufacturing transfer, pushes back Phase 1/2 data timelineSep 10Clinical readoutLyell Immunopharma, Inc.
BMS posts PRIME-HCC results; adds SOTYKTU label update, Phase 3 lung trialJul 2Weekly roundup, 7 itemsBristol Myers Squibbcisplatin